BCYC - Bicycle Therapeutics plc

NasdaqGS - NasdaqGS Real Time Price. Currency in USD
13.10
+0.70 (+5.65%)
At close: 4:00PM EDT
Stock chart is not supported by your current browser
Previous Close12.40
Open12.40
Bid12.13 x 1200
Ask13.08 x 1200
Day's Range12.40 - 13.10
52 Week Range10.60 - 13.75
Volume65,706
Avg. Volume142,762
Market Cap231.823M
Beta (3Y Monthly)N/A
PE Ratio (TTM)N/A
EPS (TTM)-62.02
Earnings DateN/A
Forward Dividend & YieldN/A (N/A)
Ex-Dividend DateN/A
1y Target EstN/A
Trade prices are not sourced from all markets
  • MarketWatch24 days ago

    Bicycle Therapeutics shares slide 10.7% in trading debut

    Biotech Bicycle Therapeutics PLC ADS fell 10.7% in their trading debut Thursday, shedding $1.50 in their first hour of trade. The company priced its initial public offering late Wednesday at $14, selling 4.3 million shares to raise $60.2 million. The stock is trading on Nasdaq, under the ticker symbol "BCYC." Proceeds of the deal will be used to fund research and development and for working capital and general corporate purposes.

  • Zacks24 days ago

    Guest Host Tonight and Tomorrow

    Guest Host Tonight and Tomorrow

  • MarketWatch24 days ago

    Bicycle Therapeutics raises $60.2 million in IPO, Ideaya Biosciences raises $50 million

    Bicycle Therapeutics plc priced its initial public offering late Wednesday at $14 per American Depositary Share, selling 4.3 million shares to raise $60.2 million. The stock will start trading later Thursday on Nasdaq, under the ticker symbol "BCYC." Separately, Ideaya Biosciences priced its IPo at $10 a share, selling 5 million shares to raise $50 million. That stock will also start trading later Thursday, under the ticker symbol "IDYA."

  • Business Wire24 days ago

    Bicycle Therapeutics Announces Pricing of Initial Public Offering

    Bicycle Therapeutics plc , a biotechnology company pioneering a new class of therapeutics based on its proprietary bicyclic peptide product platform, today announced the pricing of its initial public offering in the United States of 4,333,333 American Depositary Shares representing 4,333,333 ordinary shares at an initial public offering price of $14.00 per ADS, before underwriting discounts and commissions....

  • Benzinga26 days ago

    Bicycle Therapeutics IPO: What You Need To Know

    Bicycle Therapeutics will issue 4.33 million American depository shares, with each ADS representing one ordinary share of the company, according to the S-1 the company filed May 13. The company expects to price the offering between $14 and $16 and list its ADRs on the Nasdaq under the ticker symbol BCYC. At the midpoint of the estimated price range, the IPO will fetch the company gross proceeds of $64.9 million.